Skip to main content

Hoge Stephen's Form 4 filing

Moderna, Inc. (MRNA) · filed Dec 27, 2021

Accession no.
0001127602-21-031926
Filed
Dec 27, 2021
Trade date
Dec 23, 2021
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 13 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.71M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hoge StephenCIK 0001760669Officer (President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 23, 2021Common StockMOption exerciseAcquired+5,000$10.90+$54,5001,614,597Direct
Dec 23, 2021Common StockMOption exerciseAcquired+10,000$0.99+$9,9001,624,597Direct
Dec 23, 2021Common StockSSaleDisposed−500$239.77F2−$119,8851,624,097Direct
Dec 23, 2021Common StockSSaleDisposed−1,200$240.66F3−$288,7921,622,897Direct
Dec 23, 2021Common StockSSaleDisposed−529$242.08F4−$128,060.321,622,368Direct
Dec 23, 2021Common StockSSaleDisposed−1,000$243.09F5−$243,0901,621,368Direct
Dec 23, 2021Common StockSSaleDisposed−991$244.26F6−$242,061.661,620,377Direct
Dec 23, 2021Common StockSSaleDisposed−1,500$246.56F7−$369,8401,618,877Direct
Dec 23, 2021Common StockSSaleDisposed−1,498$247.69F8−$371,039.621,617,379Direct
Dec 23, 2021Common StockSSaleDisposed−355$248.54F9−$88,231.71,617,024Direct
Dec 23, 2021Common StockSSaleDisposed−2,227$249.71F10−$556,104.171,614,797Direct
Dec 23, 2021Common StockSSaleDisposed−5,100$250.44F11−$1,277,2441,609,697Direct
Dec 23, 2021Common StockSSaleDisposed−100$252.00−$25,2001,609,597Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 23, 2021Common StockMOption exerciseDisposed−5,000$0.00$0171,972Direct
Dec 23, 2021Common StockMOption exerciseDisposed−10,000$0.00$0197,431Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $239.39 to $240.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $240.40 to $241.13. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $241.52 to $242.44. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $242.71 to $243.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $243.96 to $244.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $246.19 to $247.06. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $247.20 to $248.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F9

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $248.24 to $248.80. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $249.27 to $250.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F11

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $250.41 to $251.90. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)